4baseCare
AI-powered precision oncology platform leveraging global genomic diversity to deliver personalized cancer diagnostics and treatment insights.
Private Company
Funding information not available
AI Company Overview
AI-powered precision oncology platform leveraging global genomic diversity to deliver personalized cancer diagnostics and treatment insights.
Technology Platform
AI-powered platform (OncoTwin) that integrates multi-modal genomic data (tissue, liquid biopsy, germline) with real-world clinical data and the Global Cancer Diversity Atlas to deliver personalized treatment insights and support clinical decision-making.
Opportunities
Risk Factors
Competitive Landscape
Competes with global diagnostic firms (e.g., Foundation Medicine, Guardant Health) and local Indian labs, but differentiates through its focus on genomic diversity from underrepresented populations, integrated SoLiQ testing approach, and AI-powered OncoTwin platform for real-world evidence generation.